Profil
Eric Quéméneur is currently the Director & EVP-Research & Development at ElsaLys Biotech SAS. Prior to his current position, he served as the Deputy CEO and Director-Research & Development at Transgene SA from 2014 to 2024.
Before that, he was the Director-Research Programs at Comité de l’énergie Atomique from 2010 to 2014.
Dr. Quéméneur holds a doctorate degree from Université Claude Bernard Lyon 1 and an undergraduate degree from Institut National des Sciences Appliquées de Lyon, which he obtained in 1986.
Anciens postes connus de Eric Quéméneur
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSGENE | Directeur Technique/Scientifique/R&D | 10/09/2024 |
| ELSALYS BIOTECH | Directeur Technique/Scientifique/R&D | - |
Comité de l’énergie Atomique
Comité de l’énergie Atomique General GovernmentGovernment Operates as agencies related to nuclear safety activities | Corporate Officer/Principal | 01/09/2014 |
Formation de Eric Quéméneur
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Université Claude Bernard Lyon 1
Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut National des Sciences Appliquées de Lyon
Institut National des Sciences Appliquées de Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Comité de l’énergie Atomique
Comité de l’énergie Atomique General GovernmentGovernment Operates as agencies related to nuclear safety activities | Government |
ElsaLys Biotech SAS
ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients | Health Technology |
















